Terms: = Liver cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
51 results:
1. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
[No Abstract] [Full Text] [Related]
2. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
5. Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung cancer: Implications for Thoracic Radiotherapy.
Kim D; Kim HJ; Wu HG; Lee JH; Kim S; Kim TM; Kim JS; Kim BH
Cancer Res Treat; 2024 Apr; 56(2):430-441. PubMed ID: 37933113
[TBL] [Abstract] [Full Text] [Related]
6. Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of tert promoter mutations.
Beaufrère A; Paisley S; Ba I; Laouirem S; Priori V; Cazier H; Favre L; Cauchy F; Lesurtel M; Calderaro J; Kannengiesser C; Paradis V
Histopathology; 2024 Feb; 84(3):473-481. PubMed ID: 37903649
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
8. A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant.
Bustamante D; Abadie J
Lab Med; 2024 May; 55(3):391-393. PubMed ID: 37477894
[TBL] [Abstract] [Full Text] [Related]
9. The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.
Innes H; Morgan MY; Hampe J; Stickel F; Buch S
Aliment Pharmacol Ther; 2023 Sep; 58(6):623-631. PubMed ID: 37470344
[TBL] [Abstract] [Full Text] [Related]
10. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
[TBL] [Abstract] [Full Text] [Related]
11. Genomic profile of Pancoast syndrome due to hepatocellular carcinoma: A case report.
Bergman DT; Zaki L; Pettus JR; Zaki BI; Amin M
Thorac Cancer; 2023 Jun; 14(18):1789-1792. PubMed ID: 37160416
[TBL] [Abstract] [Full Text] [Related]
12. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
[TBL] [Abstract] [Full Text] [Related]
13. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract] [Full Text] [Related]
14. Dyskeratosis Congenita Links Telomere Attrition to
Age-Related Systemic Energetics.
James EN; Sagi-Kiss V; Bennett M; Mycielska ME; Karen-Ng LP; Roberts T; Matta S; Dokal I; Bundy JG; Parkinson EK
J Gerontol A Biol Sci Med Sci; 2023 May; 78(5):780-789. PubMed ID: 36651908
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
[TBL] [Abstract] [Full Text] [Related]
16. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
17. Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.
Lee HW; Kim E; Cho KJ; Park HJ; Seo J; Lee H; Baek E; Choi JR; Han KH; Lee ST; Park JY
Liver Int; 2022 Oct; 42(10):2317-2326. PubMed ID: 35776657
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Fu Y; Yang Z; Hu Z; Yang Z; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Hepatol Int; 2022 Aug; 16(4):868-878. PubMed ID: 35674872
[TBL] [Abstract] [Full Text] [Related]
19. Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein.
Meng L; Fang J; Zhao L; Wang T; Yuan P; Zhao Z; Zhuang R; Lin Q; Chen H; Chen X; Zhang X; Guo Z
J Med Chem; 2022 Jun; 65(12):8245-8257. PubMed ID: 35658448
[TBL] [Abstract] [Full Text] [Related]
20. Serum tert C228T is an important predictor of non-viral liver cancer with fatty liver disease.
Akuta N; Kawamura Y; Suzuki F; Kobayashi M; Arase Y; Saitoh S; Muraishi N; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Ikeda K; Kumada H
Hepatol Int; 2022 Apr; 16(2):412-422. PubMed ID: 35306637
[TBL] [Abstract] [Full Text] [Related]
[Next]
